Activation of the Rho/Rho Kinase Signaling Pathway Is Involved in Cell Death of Corneal Endothelium.
暂无分享,去创建一个
N. Koizumi | S. Kinoshita | Keita Fujii | Naoki Okumura | Miu Kitahara | Takato Kagami | Nakahara Makiko
[1] T. Shiina,et al. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction , 2016, Scientific Reports.
[2] Rongshi Li,et al. Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential. , 2016, Journal of medicinal chemistry.
[3] N. Koizumi,et al. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing. , 2016, Investigative ophthalmology & visual science.
[4] A. Jun,et al. Fuchs endothelial corneal dystrophy: current perspectives , 2016, Clinical ophthalmology.
[5] N. Koizumi,et al. Involvement of ZEB1 and Snail1 in excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy , 2015, Laboratory Investigation.
[6] M. Araie,et al. Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials. , 2015, JAMA ophthalmology.
[7] Toshihiro Inoue,et al. Intra‐ocular pressure‐lowering effects of a Rho kinase inhibitor, ripasudil (K‐115), over 24 hours in primary open‐angle glaucoma and ocular hypertension: a randomized, open‐label, crossover study , 2015, Acta ophthalmologica.
[8] A. Jun,et al. N-Acetylcysteine increases corneal endothelial cell survival in a mouse model of Fuchs endothelial corneal dystrophy. , 2014, Experimental eye research.
[9] J. Qian,et al. Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy. , 2014, Investigative ophthalmology & visual science.
[10] U. Jurkunas,et al. Sulforaphane decreases endothelial cell apoptosis in fuchs endothelial corneal dystrophy: a novel treatment. , 2013, Investigative ophthalmology & visual science.
[11] N. Koizumi,et al. Rho-Associated Kinase Inhibitor Eye Drop Treatment as a Possible Medical Treatment for Fuchs Corneal Dystrophy , 2013, Cornea.
[12] J. Cunha-Vaz,et al. Combination of intravitreal injection of Pegaptanib plus progressive PRP versus full PRP alone in patients with High Risk Proliferative Diabetic Retinopathy , 2013 .
[13] N. Koizumi,et al. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. , 2013, Investigative ophthalmology & visual science.
[14] N. Koizumi,et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. , 2012, The American journal of pathology.
[15] A. Jun,et al. An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. , 2012, Human molecular genetics.
[16] U. Jurkunas,et al. Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy. , 2010, The American journal of pathology.
[17] Yoshiki Sasai,et al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. , 2010, Cell stem cell.
[18] N. Koizumi,et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. , 2009, Investigative ophthalmology & visual science.
[19] M. Olson. Applications for ROCK kinase inhibition. , 2008, Current opinion in cell biology.
[20] S. Nishikawa,et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells , 2007, Nature Biotechnology.
[21] Jianjian Shi,et al. Rho kinase in the regulation of cell death and survival , 2007, Archivum Immunologiae et Therapiae Experimentalis.
[22] A. Ridley,et al. Prostate-derived Sterile 20-like Kinase 2 (PSK2) Regulates Apoptotic Morphology via C-Jun N-terminal Kinase and Rho Kinase-1* , 2006, Journal of Biological Chemistry.
[23] C. Marshall,et al. ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. , 2006, Cancer cell.
[24] V. Allan,et al. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells , 2005, Journal of Cell Science.
[25] J. Vasiliev,et al. Marginal blebbing during the early stages of TNF‐induced apoptosis indicates alteration in actomyosin contractility , 2004, Cell biology international.
[26] Krister Wennerberg,et al. Rho and Rac Take Center Stage , 2004, Cell.
[27] S. Hazen,et al. Eosinophil peroxidase catalyzes JNK‐mediated membrane blebbing in a Rho kinase‐dependent manner , 2003, Journal of leukocyte biology.
[28] J. Lai,et al. Caspase activation during phorbol ester-induced apoptosis requires ROCK-dependent myosin-mediated contraction , 2003, Journal of Cell Science.
[29] M. Crow,et al. Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. , 2003, Biochemical and biophysical research communications.
[30] M. Crow,et al. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[31] J. Bertoglio,et al. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing , 2001, Nature Cell Biology.
[32] E. Sahai,et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.
[33] M. Boulton,et al. Apoptosis in the endothelium of human corneas for transplantation. , 2000, Investigative ophthalmology & visual science.
[34] H. Kaufman,et al. Central cornea guttata. Incidence in the general population. , 1967, American journal of ophthalmology.